Home » Topics » Regulatory » Patents

Patents
RSS

Sankyo patents series with dual NK1/NK2-antagonist activity

Sep. 21, 1998

Japan Energy presents new HIV protease inhibitors

Sep. 21, 1998

Meiji Seika's new macrolides active against Gram-positive microorganisms

Sep. 21, 1998

Novel antiinflammatory azulenes disclosed by Kotobuki

Sep. 21, 1998

Inhibitors of telomerase focus of investigation at CRC Technology, U. Texas

Sep. 17, 1998

Lilly discovers inhibitors of PSA enzymatic activity for cancer, BPH

Sep. 16, 1998

Arylsulfonamides as inhibitors of PLA2, cytokine release and neurodegeneration

Sep. 16, 1998

Anthraquinone telomerase inhibitors developed at CRC Technology

Sep. 16, 1998

Integrin antagonists discovered as part of Lilly/Cor Therapeutics collaboration

Sep. 16, 1998

Amgen describes preparation and use of KGF proteins

Sep. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...